Linkage and association with the NOS2A locus on chromosome 17q11 in multiple sclerosis

被引:49
作者
Barcellos, LF
Begovich, AB
Reynolds, RL
Caillier, SJ
Brassat, D
Schmidt, S
Grams, SE
Walker, K
Steiner, LL
Cree, BAC
Stillman, A
Lincoln, RR
Pericak-Vance, MA
Haines, JL
Erlich, HA
Hauser, SL
Oksenberg, JR
机构
[1] Univ Calif San Francisco, Dept Neurol, Sch Med, San Francisco, CA 94143 USA
[2] Univ Calif Berkeley, Sch Publ Hlth, Div Epidemiol, Berkeley, CA 94720 USA
[3] Roche Mol Syst Inc, Dept Human Genet, Alameda, CA USA
[4] Duke Univ, Ctr Med, Dept Med, Ctr Human Genet, Durham, NC USA
[5] Vanderbilt Univ, Dept Physiol & Mol Biophys, Program Human Genet, Nashville, TN USA
关键词
D O I
10.1002/ana.20092
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
A large body of research supports a multifactorial cause in multiple sclerosis (MS), with an underlying genetic susceptibility likely acting in concert with undefined environmental exposures. Here, we used a highly efficient multilocus genotyping assay to study single nucleotide polymorphisms representing variation in 34 genes from inflammatory pathways in a well-characterized MS familial data set. Evidence of transmission distortion was present for several polymorphisms. Results for the NOS2A locus (exon 10 C/T, D346D) on chromosome 17q11 remained significant after correction for multiple testing and were reproduced in a second independent African American MS data set. In addition, linkage to a NOS2A promoter region polymorphism, (CCTTT)(n), was present in a third data set of multicase MS families. Our results provide strong evidence for linkage and association to a new candidate disease gene on chromosome 17q11 in MS and suggest that variation within NOS2A or a nearby locus contributes to disease susceptibility.
引用
收藏
页码:793 / 800
页数:8
相关论文
共 50 条
[1]   Merlin-rapid analysis of dense genetic maps using sparse gene flow trees [J].
Abecasis, GR ;
Cherny, SS ;
Cookson, WO ;
Cardon, LR .
NATURE GENETICS, 2002, 30 (01) :97-101
[2]   Nitric oxide as an activity marker in multiple sclerosis [J].
Acar, G ;
Idiman, F ;
Idiman, E ;
Kirkali, G ;
Çakmakçi, H ;
Özakbas, S .
JOURNAL OF NEUROLOGY, 2003, 250 (05) :588-592
[3]  
Barcellos LF, 2002, BRAIN, V125, P150
[4]   HLA-DR2 dose effect on susceptibility to multiple sclerosis and influence on disease course [J].
Barcellos, LF ;
Oksenberg, JR ;
Begovich, AB ;
Martin, ER ;
Schmidt, S ;
Vittinghoff, E ;
Goodin, DS ;
Pelletier, D ;
Lincoln, RR ;
Bucher, P ;
Swerdlin, A ;
Perick-Vance, MA ;
Haines, JL ;
Hauser, SL .
AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 72 (03) :710-716
[5]   No association of inducible nitric oxide synthase gene (NOS2A) to multiple sclerosis [J].
Blanco, Y ;
Yagüe, J ;
Graus, F ;
Saiz, A .
JOURNAL OF NEUROLOGY, 2003, 250 (05) :598-600
[6]   INDUCTION OF NITRIC-OXIDE SYNTHASE IN DEMYELINATING REGIONS OF MULTIPLE-SCLEROSIS BRAINS [J].
BO, L ;
DAWSON, TM ;
WESSELINGH, S ;
MORK, S ;
CHOI, S ;
KONG, PA ;
HANLEY, D ;
TRAPP, BD .
ANNALS OF NEUROLOGY, 1994, 36 (05) :778-786
[7]   Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease [J].
Botstein, D ;
Risch, N .
NATURE GENETICS, 2003, 33 (Suppl 3) :228-237
[8]  
Brenner T, 1997, J IMMUNOL, V158, P2940
[9]   A genome screen for multiple sclerosis in Italian families [J].
Broadley, S ;
Sawcer, S ;
D'Alfonso, S ;
Hensiek, A ;
Coraddu, F ;
Gray, J ;
Roxburgh, R ;
Clayton, D ;
Buttinelli, C ;
Quattrone, A ;
Trojano, M ;
Massacesi, L ;
Compston, A .
GENES AND IMMUNITY, 2001, 2 (04) :205-210
[10]   The genetics of multiple sclerosis: principles, background and updated results of the United Kingdom systematic genome screen [J].
Chataway, J ;
Feakes, R ;
Coraddu, F ;
Gray, J ;
Deans, J ;
Fraser, M ;
Robertson, N ;
Broadley, S ;
Jones, H ;
Clayton, D ;
Goodfellow, P ;
Sawcer, S ;
Compston, A .
BRAIN, 1998, 121 :1869-1887